SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-041080
Filing Date
2021-10-21
Accepted
2021-10-21 20:40:24
Documents
3
Period of Report
2021-10-21

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 8416
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4467
3 EX-24.2 DOCUMENT attachment2.htm EX-24.2 4389
  Complete submission text file 0000899243-21-041080.txt   19234
Mailing Address 71 KINGSWAY LONDON X0 WC2B 6ST
Business Address 71 KINGSWAY LONDON X0 WC2B 6ST 44 20 7421 7081
SV7 Impact Medicine Fund LP (Reporting) CIK: 0001780602 (see all company filings)

State of Incorp.: X0 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40925 | Film No.: 211338419

Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Issuer) CIK: 0001840233 (see all company filings)

IRS No.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 71 KINGSWAY LONDON X0 WC2B 6ST
Business Address 71 KINGSWAY LONDON X0 WC2B 6ST 44 20 7421 7081
SV7 (IMF) GP LLP (Reporting) CIK: 0001889859 (see all company filings)

State of Incorp.: X0
Type: 3 | Act: 34 | File No.: 001-40925 | Film No.: 211338418